These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 4134872

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Study on the immunological heterogeneity of Clostridium botulinum B type toxin.
    Rymkiewicz D, Sawicki J, Brühl A.
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):709-14. PubMed ID: 398207
    [Abstract] [Full Text] [Related]

  • 3. The antigenicity of Clostridium botulinum type C toxin administered per os.
    Jansen BC, Knoetze PC, Visser F.
    Onderstepoort J Vet Res; 1970 Sep; 37(3):169-71. PubMed ID: 4949136
    [No Abstract] [Full Text] [Related]

  • 4. The toxic antigenic factors produced by Clostridium botulinum types C and D.
    Jansen BC.
    Onderstepoort J Vet Res; 1971 Jun; 38(2):93-8. PubMed ID: 4950122
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clostridium botulinum subtype Ba.
    Giménez DF.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [Abstract] [Full Text] [Related]

  • 7. [Identification of strain B 657 of Clostridium botulinum].
    Giménez DF, Giménez JA.
    Rev Argent Microbiol; 1983 May; 15(1):51-5. PubMed ID: 6400761
    [Abstract] [Full Text] [Related]

  • 8. Antitoxin responses to Clostridium botulinum vaccines types C and D in guinea pigs.
    Mathews AG.
    Dev Biol Stand; 1976 May; 32():193-201. PubMed ID: 793915
    [Abstract] [Full Text] [Related]

  • 9. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF, Ciccarelli AS.
    Medicina (B Aires); 1972 May; 32(6):596-606. PubMed ID: 4576316
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Detection of type E botulinal toxin in cultures by fluorescent-antibody microscopy.
    Aalvik B, Sakaguchi G, Riemann H.
    Appl Microbiol; 1973 Jan; 25(1):153-4. PubMed ID: 4568886
    [Abstract] [Full Text] [Related]

  • 14. Kinetics study of immunological response to Clostridium botulinum toxin.
    Dezfulian M, Bitar RA, Bartlett JG.
    J Clin Microbiol; 1987 Jul; 25(7):1336-7. PubMed ID: 3301895
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
    Dezfulian M, Bartlett JG.
    J Clin Microbiol; 1984 May; 19(5):645-8. PubMed ID: 6376538
    [Abstract] [Full Text] [Related]

  • 18. An international survey of clostridial sera and vaccines.
    Davidson I.
    Dev Biol Stand; 1976 May; 32():3-14. PubMed ID: 187508
    [Abstract] [Full Text] [Related]

  • 19. Determination of soluble antigens of Clostridium botulinum A by chemiluminescent--immunosorbent assay (CLISA).
    Ligieza J, Michalik M, Reiss J, Grzybowski J.
    Arch Immunol Ther Exp (Warsz); 1986 May; 34(2):189-95. PubMed ID: 2431667
    [Abstract] [Full Text] [Related]

  • 20. A comparison of the pharmacological properties of Clostridium botulinum type C1 and C2 toxins.
    Simpson LL.
    J Pharmacol Exp Ther; 1982 Dec; 223(3):695-701. PubMed ID: 6292397
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.